{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:34:18Z","timestamp":1771684458672,"version":"3.50.1"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.2169\/internalmedicine.5283-25","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T22:07:41Z","timestamp":1745014061000},"page":"2051-2056","source":"Crossref","is-referenced-by-count":1,"title":["An Autopsy for Persistent Coronavirus Disease 2019 Pneumonia during Follicular Lymphoma Treatment"],"prefix":"10.2169","volume":"64","author":[{"given":"Hikaru","family":"Mamizu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihiro","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Miyagatani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Mamizu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuru","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Atabati E, Dehghani-Samani A, Mortazavimoghaddam SG. Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis and pulmonary hypertension: a narrative review. Can J Respir Ther 56: 1-9, 2020.","DOI":"10.29390\/cjrt-2020-021"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Horby P, Lim WS, Emberson JR; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384: 693-704, 2021.","DOI":"10.1056\/NEJMoa2021436"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ranjbar K, Moghadami M, Mirahmadizadeh A, et al. Methyprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blind randomized controlled trial. BMC Infect Dis 21: 337, 2021.","DOI":"10.1186\/s12879-021-06045-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Salvarani C, Massari M, Costantini M, et al. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial. Eur Respir J 60: 2200025, 2022.","DOI":"10.1183\/13993003.00025-2022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. John AE, Joseph C, Jenkins G, Tatler AL. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev 302: 228-240, 2021.","DOI":"10.1111\/imr.12977"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observationnal study of corticosteroid treatment. Ann Am Thorac Soc 18: 799-806, 2021.","DOI":"10.1513\/AnnalsATS.202008-1002OC"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yomota M, Tanaka M, Kobayashi T, et al. Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: a case report. Respirol Case Rep 12: e01298, 2024.","DOI":"10.1002\/rcr2.1298"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ueda Y, Asakura S, Wada S, Saito T, Yano T. Prolonged COVID-19 in an immunocompromised patient treated with obinutuzumab and bendamustine for follicular lymphoma. Intern Med 61: 2523-2526, 2022.","DOI":"10.2169\/internalmedicine.9136-21"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tvito A, Ronson A, Ghosheh R, et al. Anti-CD20 monoclonal antibodies inhibit seropositive response to COVID-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment. Exp Hematol 107: 20-23, 2022.","DOI":"10.1016\/j.exphem.2021.12.396"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Nazi I, Kelton JG, Larch\u00e9 M, et al. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood 122: 1946-1953, 2013.","DOI":"10.1182\/blood-2013-04-494096"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishio T, Tsukamoto S, Yokoyama E, et al. Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma. Ann Hematol 102: 1421-1431, 2023.","DOI":"10.1007\/s00277-023-05204-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pearce FA, Lim SH, Bythell M, et al. Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. Lancet Rheumatol 5: e461-e473, 2023.","DOI":"10.1016\/S2665-9913(23)00160-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ichikawa T, Tamura T, Takahata M, et al. Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: a prospective study. Br J Haematol 204: 815-820, 2024.","DOI":"10.1111\/bjh.19143"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Azuly H, Shafat T, Grupel D, et al.; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Preventing severe COVID-19 with tixagevimab-cilgavimab in hematological patients treated with anti-CD20 monoclonal antibodies: an international multicenter study. Infect Dis Ther 14: 167-180, 2025.","DOI":"10.1007\/s40121-024-01089-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Iida S, Arashiro T, Suzuki T. Insights into pathology and pathogenesis of coronavirus disease 2019 from a histopathological and immunological perspective. JMA J 4: 179-186, 2021.","DOI":"10.31662\/jmaj.2021-0041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med 377: 562-572, 2017.","DOI":"10.1056\/NEJMra1608077"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tsukada A, Suzuki M, Kishino Y, et al. A kidney transplant patient who died of COVID-19-associated severe acute respiratory distress syndrome. Intern Med 60: 2297-2300, 2021.","DOI":"10.2169\/internalmedicine.7089-21"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kakeya H. Corticosteroid and infection. Nihon Naika Gakkai Zasshi (J Jpn Soc Intern Med) 108: 2268-2274, 2019 (in Japanese).","DOI":"10.2169\/naika.108.2268"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang J, Yang Q, Zhang P, Sheng J, Zhou J, Qu T. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Crit Care 24: 299, 2020.","DOI":"10.1186\/s13054-020-03046-7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Johannesdottir SA, Horv\u00e1th-Puh\u00f3 E, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173: 743-752, 2013.","DOI":"10.1001\/jamainternmed.2013.122"},{"key":"21","unstructured":"21. An official websites of the United States government. Interim clinical considerations for use of COVID-19 vaccines in the United States. [cited 2025 Feb 10]. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html#table-02"},{"key":"22","unstructured":"22. Aggarwal NR, Nordwall J, Braun DL, et al. Viral and host factors are associated with mortality in hospitalized patients with COVID-19. Clin Infect Dis 78: 1490-1503, 2024."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jensen TO, Harper K, Gupta S, et al. Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study. Clin Infect Dis 79: 1394-1403, 2024.","DOI":"10.1093\/cid\/ciae469"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/13\/64_5283-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:46:31Z","timestamp":1751687191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/13\/64_5283-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5283-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"5283-25"}}